IGM Biosciences Statistics

Total Valuation

IGM Biosciences has a market cap or net worth of $71.13 million. The enterprise value is -$71.05 million.

Market Cap	71.13M
Enterprise Value	-71.05M

Important Dates

The next estimated earnings date is Tuesday, May 20, 2025, after market close.

Earnings Date	May 20, 2025
Ex-Dividend Date	n/a

Share Statistics

IGM Biosciences has 59.78 million shares outstanding. The number of shares has increased by 15.68% in one year.

Current Share Class	34.39M
Shares Outstanding	59.78M
Shares Change (YoY)	+15.68%
Shares Change (QoQ)	+0.32%
Owned by Insiders (%)	2.45%
Owned by Institutions (%)	11.13%
Float	10.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	25.53
Forward PS	5.13
PB Ratio	1.40
P/TBV Ratio	1.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.14, with a Debt / Equity ratio of 0.94.

Current Ratio	5.14
Quick Ratio	4.90
Debt / Equity	0.94
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -155.76% and return on invested capital (ROIC) is -72.02%.

Return on Equity (ROE)	-155.76%
Return on Assets (ROA)	-35.23%
Return on Invested Capital (ROIC)	-72.02%
Return on Capital Employed (ROCE)	-85.16%
Revenue Per Employee	$17,980
Profits Per Employee	-$1.31M
Employee Count	149
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.26% in the last 52 weeks. The beta is 0.60, so IGM Biosciences's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-87.26%
50-Day Moving Average	1.25
200-Day Moving Average	7.27
Relative Strength Index (RSI)	44.82
Average Volume (20 Days)	159,872

Short Selling Information

The latest short interest is 874,446, so 1.46% of the outstanding shares have been sold short.

Short Interest	874,446
Short Previous Month	894,056
Short % of Shares Out	1.46%
Short % of Float	8.19%
Short Ratio (days to cover)	4.86

Income Statement

In the last 12 months, IGM Biosciences had revenue of $2.68 million and -$195.80 million in losses. Loss per share was -$3.24.

Revenue	2.68M
Gross Profit	-152.51M
Operating Income	-194.22M
Pretax Income	-236.33M
Net Income	-195.80M
EBITDA	-185.11M
EBIT	-194.22M
Loss Per Share	-$3.24

Full Income Statement

Balance Sheet

The company has $183.79 million in cash and $45.19 million in debt, giving a net cash position of $138.60 million or $2.32 per share.

Cash & Cash Equivalents	183.79M
Total Debt	45.19M
Net Cash	138.60M
Net Cash Per Share	$2.32
Equity (Book Value)	48.17M
Book Value Per Share	0.81
Working Capital	155.98M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$153.00 million and capital expenditures -$5.85 million, giving a free cash flow of -$158.85 million.

Operating Cash Flow	-153.00M
Capital Expenditures	-5.85M
Free Cash Flow	-158.85M
FCF Per Share	-$2.66

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-7,249.61%
Pretax Margin	-7,308.51%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IGM Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.68%
Shareholder Yield	-15.68%
Earnings Yield	-289.87%
FCF Yield	-235.17%

Analyst Forecast

The average price target for IGM Biosciences is $6.14, which is 415.97% higher than the current price. The consensus rating is "Hold".

Price Target	$6.14
Price Target Difference	415.97%
Analyst Consensus	Hold
Analyst Count	8
Revenue Growth Forecast (5Y)	33.50%
EPS Growth Forecast (5Y)	-23.89%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IGM Biosciences has an Altman Z-Score of -5.31 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.31
Piotroski F-Score	3